KI-Beratung Beta

Produktbild: Targeted Therapy for the Central Nervous System

Targeted Therapy for the Central Nervous System Formulation, Clinical Challenges, and Regulatory Strategies

Fr. 263.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Targeted Therapy for the Central Nervous System: Formulation, Clinical Challenges, and Regulatory Strategies presents research on various delivery methods of drugs to the central nervous system and brain. This volume examines targeted therapies for neurodegenerative disorders and succinctly outlines...

Beschreibung

Targeted Therapy for the Central Nervous System: Formulation, Clinical Challenges, and Regulatory Strategies presents research on various delivery methods of drugs to the central nervous system and brain. This volume examines targeted therapies for neurodegenerative disorders and succinctly outlines the future of drug delivery systems, highlighting significant advancements specifically relating to central nervous system delivery. This book will be of great interest to researchers working in the field of neuroscience and pharmacology as well as clinicians (pharmacists, radiologists, psychiatrists).

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

11.10.2024

Herausgeber Viral Patel + weitere
Verlag Elsevier Science & Technology

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

11.10.2024

Herausgeber
Verlag Elsevier Science & Technology
Seitenzahl

628

Maße (L/B/H)

23.4/18.8/3 cm

Gewicht

1216 g

Sprache

Englisch

ISBN

978-0-443-23841-3

EU-Ansprechpartner

Elsevier B.V.
Radarweg 29
1043 NX Amsterdam
NL
productsafety@elsevier.com

Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Targeted Therapy for the Central Nervous System
  • Part I. Brief About Pathophysiology
    1. Etiology and Treatment Challenges for Neurodegenerative Disorders
    2. Etiology and Treatment Challenges for Neurotraumatic and Psychiatric Disorders
    3. Barriers to Progress of Neurotherapeutics: Getting Drugs to the Brain

    Part II. Novel Formulation Strategies for Targeted Therapy
    4. IGF-II Conjugated Nanocarrier for Brain Targeting
    5. ApoE Potential in CNS Drugs Targeting and as CNS Therapeutic
    6. Transferrin Functionalized Nanoparticles for Targeted Drug Delivery in Biological Systems
    7. Surface Engineered Multimodal Magnetic Nanoparticles for Neurodegenerative Diseases
    8. Tau Targeting Biomimetic Nanoparticles
    9. Stem Cell Therapy as a Novel Concept to Combat CNS Disorders
    10. SR-B1 Receptor Targeting in CNS Disorders
    11. ß- and ¿-secretases as Therapeutic Targets for Alzheimer’s Disease
    12. Minimally Invasive Nasal Depot (MIND) Technique for Direct BDNF AntagoNAT Delivery to the Brain
    13. Immunosuppressive and Immunomodulatory Therapies
    14. CRISPR/Cas9 Gene Editing: A New Hope for Alzheimer’s Disease
    15. Artificial Intelligence: Ways and Means for Central Nervous System (CNS) Delivery
    16. Carbon Dots as Versatile Nano-architectures for the Treatment of Neurological Disorders

    Part III. Clinical Challenges and Regulatory Updates
    17. Animal Models for Clinical Evaluation
    18. Medical Device
    Contributors: Abhishek Swarnkar, Viral Patel, Amit Patel, Manan Raval
    19. Regulation of Nanomaterials and Nanomedicines for Clinical Applications
    20. Regulatory Considerations for the use of Biomarkers and Personalized Medicine in CNS Drug Development
    21. Regulatory Toxicology Testing for Pharmaceuticals
    22. Emerging Challenges and Opportunities for Drug and Drug Product Registrations
    23. CRISPR/Cas9 Gene Editing: A New Hope for Parkinson’s Disease